Report Detail

Request for Sample of this report

Pharma & Healthcare Global Procalcitonin Antibody Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM3309761
    • |
  • 12 April, 2019
    • |
  • Global
    • |
  • 135 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli.Procalcitonin Antibody refers to the specific protein which can qualitatively and quantitatively detect the PCT level. PCT level is a parameter for the diagnosis and monitoring of bacterial inflammatory diseases

Scope of the Report:
Sepsis is a life-threatening organ dysfunction caused by an excessive host immune response to a serious infection. According to the Centers for Disease Control and Prevention (CDC), 1.6 million Americans suffered from sepsis in 2011, of which about 260,000 did not survive. PCT can play a critical role in addressing this clinical challenge and has become a key component of successful sepsis protocols across the U.S. and Europe. PCT levels increase precipitously in patients with severe bacterial infection. PCT is therefore an extremely important biomarker enabling specific differentiation between a severe bacterial infection and other causes of inflammatory reactions.
The technical barriers of procalcitonin antibody are high and the procalcitonin antibody production concentrated large companies including Thermo Fisher, Roche Diagnostics, bioMerieux, HyTest, etc. The sales revenue of top five manufacturers accounted for 37.9% in 2016. Thermo Fisher is the largest manufacturer in the world, which sales reached 2.48g in China.
The manufacture region is concentrated in South China, East China and Southwest China, of which East China is the largest region with the share 24.28% in 2016. The sales shares of Southwest China and South China were 15.59% and 14.79%.
There are companies adding new capacities and aims at the cost and quality leadership which shall improve profitability. As the same time, companies are focusing on technological innovation, equipment upgrades, and process improvements, to reduce costs and improve quality. The competition in procalcitonin antibody market will become more intense.

The worldwide market for Procalcitonin Antibody is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Procalcitonin Antibody in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Thermo Fisher
Roche Diagnostics
bioMerieux
HyTest
Wondfo
Ningbo Medicalsystem Biotechnology
Snibe
Vazyme Biotech
Getein Biotech
Hotgen Biotech
Lumigenex
Shanghai Medicine'nest Pharmaceutical
Kitgen
Beijing KeyGen
Fantibody

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Polyclonal Procalcitonin Antibody
Monoclonal Procalcitonin Antibody

Market Segment by Applications, can be divided into
Hospital
Medical research institutions
Others

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Procalcitonin Antibody product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Procalcitonin Antibody, with price, sales, revenue and global market share of Procalcitonin Antibody in 2017 and 2018.
Chapter 3, the Procalcitonin Antibody competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Procalcitonin Antibody breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Procalcitonin Antibody market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Procalcitonin Antibody sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Procalcitonin Antibody Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Polyclonal Procalcitonin Antibody
      • 1.2.2 Monoclonal Procalcitonin Antibody
    • 1.3 Market Analysis by Applications
      • 1.3.1 Hospital
      • 1.3.2 Medical research institutions
      • 1.3.3 Others
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Thermo Fisher
      • 2.1.1 Business Overview
      • 2.1.2 Procalcitonin Antibody Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Thermo Fisher Procalcitonin Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Roche Diagnostics
      • 2.2.1 Business Overview
      • 2.2.2 Procalcitonin Antibody Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Roche Diagnostics Procalcitonin Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 bioMerieux
      • 2.3.1 Business Overview
      • 2.3.2 Procalcitonin Antibody Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 bioMerieux Procalcitonin Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 HyTest
      • 2.4.1 Business Overview
      • 2.4.2 Procalcitonin Antibody Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 HyTest Procalcitonin Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Wondfo
      • 2.5.1 Business Overview
      • 2.5.2 Procalcitonin Antibody Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Wondfo Procalcitonin Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Ningbo Medicalsystem Biotechnology
      • 2.6.1 Business Overview
      • 2.6.2 Procalcitonin Antibody Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Ningbo Medicalsystem Biotechnology Procalcitonin Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Snibe
      • 2.7.1 Business Overview
      • 2.7.2 Procalcitonin Antibody Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Snibe Procalcitonin Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Vazyme Biotech
      • 2.8.1 Business Overview
      • 2.8.2 Procalcitonin Antibody Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Vazyme Biotech Procalcitonin Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Getein Biotech
      • 2.9.1 Business Overview
      • 2.9.2 Procalcitonin Antibody Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Getein Biotech Procalcitonin Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Hotgen Biotech
      • 2.10.1 Business Overview
      • 2.10.2 Procalcitonin Antibody Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Hotgen Biotech Procalcitonin Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Lumigenex
      • 2.11.1 Business Overview
      • 2.11.2 Procalcitonin Antibody Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Lumigenex Procalcitonin Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Shanghai Medicine'nest Pharmaceutical
      • 2.12.1 Business Overview
      • 2.12.2 Procalcitonin Antibody Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Shanghai Medicine'nest Pharmaceutical Procalcitonin Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Kitgen
      • 2.13.1 Business Overview
      • 2.13.2 Procalcitonin Antibody Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Kitgen Procalcitonin Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 Beijing KeyGen
      • 2.14.1 Business Overview
      • 2.14.2 Procalcitonin Antibody Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 Beijing KeyGen Procalcitonin Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.15 Fantibody
      • 2.15.1 Business Overview
      • 2.15.2 Procalcitonin Antibody Type and Applications
        • 2.15.2.1 Product A
        • 2.15.2.2 Product B
      • 2.15.3 Fantibody Procalcitonin Antibody Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Procalcitonin Antibody Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Procalcitonin Antibody Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Procalcitonin Antibody Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Procalcitonin Antibody Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Procalcitonin Antibody Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Procalcitonin Antibody Market Analysis by Regions

    • 4.1 Global Procalcitonin Antibody Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Procalcitonin Antibody Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Procalcitonin Antibody Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Procalcitonin Antibody Sales and Growth Rate (2014-2019)
    • 4.3 Europe Procalcitonin Antibody Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Procalcitonin Antibody Sales and Growth Rate (2014-2019)
    • 4.5 South America Procalcitonin Antibody Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Procalcitonin Antibody Sales and Growth Rate (2014-2019)

    5 North America Procalcitonin Antibody by Country

    • 5.1 North America Procalcitonin Antibody Sales, Revenue and Market Share by Country
      • 5.1.1 North America Procalcitonin Antibody Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Procalcitonin Antibody Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Procalcitonin Antibody Sales and Growth Rate (2014-2019)
    • 5.3 Canada Procalcitonin Antibody Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Procalcitonin Antibody Sales and Growth Rate (2014-2019)

    6 Europe Procalcitonin Antibody by Country

    • 6.1 Europe Procalcitonin Antibody Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Procalcitonin Antibody Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Procalcitonin Antibody Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Procalcitonin Antibody Sales and Growth Rate (2014-2019)
    • 6.3 UK Procalcitonin Antibody Sales and Growth Rate (2014-2019)
    • 6.4 France Procalcitonin Antibody Sales and Growth Rate (2014-2019)
    • 6.5 Russia Procalcitonin Antibody Sales and Growth Rate (2014-2019)
    • 6.6 Italy Procalcitonin Antibody Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Procalcitonin Antibody by Country

    • 7.1 Asia-Pacific Procalcitonin Antibody Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Procalcitonin Antibody Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Procalcitonin Antibody Revenue and Market Share by Country (2014-2019)
    • 7.2 China Procalcitonin Antibody Sales and Growth Rate (2014-2019)
    • 7.3 Japan Procalcitonin Antibody Sales and Growth Rate (2014-2019)
    • 7.4 Korea Procalcitonin Antibody Sales and Growth Rate (2014-2019)
    • 7.5 India Procalcitonin Antibody Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Procalcitonin Antibody Sales and Growth Rate (2014-2019)

    8 South America Procalcitonin Antibody by Country

    • 8.1 South America Procalcitonin Antibody Sales, Revenue and Market Share by Country
      • 8.1.1 South America Procalcitonin Antibody Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Procalcitonin Antibody Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Procalcitonin Antibody Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Procalcitonin Antibody Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Procalcitonin Antibody Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Procalcitonin Antibody by Countries

    • 9.1 Middle East and Africa Procalcitonin Antibody Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Procalcitonin Antibody Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Procalcitonin Antibody Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Procalcitonin Antibody Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Procalcitonin Antibody Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Procalcitonin Antibody Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Procalcitonin Antibody Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Procalcitonin Antibody Sales and Growth Rate (2014-2019)

    10 Global Procalcitonin Antibody Market Segment by Type

    • 10.1 Global Procalcitonin Antibody Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Procalcitonin Antibody Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Procalcitonin Antibody Revenue and Market Share by Type (2014-2019)
    • 10.2 Polyclonal Procalcitonin Antibody Sales Growth and Price
      • 10.2.1 Global Polyclonal Procalcitonin Antibody Sales Growth (2014-2019)
      • 10.2.2 Global Polyclonal Procalcitonin Antibody Price (2014-2019)
    • 10.3 Monoclonal Procalcitonin Antibody Sales Growth and Price
      • 10.3.1 Global Monoclonal Procalcitonin Antibody Sales Growth (2014-2019)
      • 10.3.2 Global Monoclonal Procalcitonin Antibody Price (2014-2019)

    11 Global Procalcitonin Antibody Market Segment by Application

    • 11.1 Global Procalcitonin Antibody Sales Market Share by Application (2014-2019)
    • 11.2 Hospital Sales Growth (2014-2019)
    • 11.3 Medical research institutions Sales Growth (2014-2019)
    • 11.4 Others Sales Growth (2014-2019)

    12 Procalcitonin Antibody Market Forecast (2019-2024)

    • 12.1 Global Procalcitonin Antibody Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Procalcitonin Antibody Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Procalcitonin Antibody Market Forecast (2019-2024)
      • 12.2.2 Europe Procalcitonin Antibody Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Procalcitonin Antibody Market Forecast (2019-2024)
      • 12.2.4 South America Procalcitonin Antibody Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Procalcitonin Antibody Market Forecast (2019-2024)
    • 12.3 Procalcitonin Antibody Market Forecast by Type (2019-2024)
      • 12.3.1 Global Procalcitonin Antibody Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Procalcitonin Antibody Market Share Forecast by Type (2019-2024)
    • 12.4 Procalcitonin Antibody Market Forecast by Application (2019-2024)
      • 12.4.1 Global Procalcitonin Antibody Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Procalcitonin Antibody Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Procalcitonin Antibody . Industry analysis & Market Report on Procalcitonin Antibody is a syndicated market report, published as Global Procalcitonin Antibody Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Procalcitonin Antibody market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,735.28
      		4,102.92
      		5,470.56
      		3,208.56
      		4,812.84
      		6,417.12
      		547,021.20
      		820,531.80
      		1,094,042.40
      		290,336.40
      		435,504.60
      		580,672.80
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo